NCT06607913

Brief Summary

The aging Veteran population has more frequent inpatient hospitalization than non-Veterans. In addition, older Veterans have an inability to fully recover muscle mass and function after hospital-acquired weakness. The problem of hospital-acquired weakness is greatly increased in at-risk Veteran populations such as those with chronic kidney disease (CKD). The purpose of this collaborative study involving Denver and Baltimore VAMC sites is to improve health through the detection and rehabilitation management of hospital-acquired weakness in those with CKD. The study goals include identifying and monitoring the optimal muscle assessment sites in clinical settings, examining how muscle health impacts length of hospital stay and physical resilience, and determining how home-based and supervised exercise comparatively addresses post-hospitalization physical resilience using performance tests and Veteran feedback.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
41mo left

Started Apr 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Apr 2025Sep 2029

First Submitted

Initial submission to the registry

September 19, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 23, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

April 11, 2025

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2029

Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

3.5 years

First QC Date

September 19, 2024

Last Update Submit

April 29, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Vastus Lateralis Muscle Thickness

    A measure of the Vastus Lateralis muscle will be examined using ultrasound technology to determine the muscle size, quality, and composition. Post-intervention levels will be compared to 6 months after the cessation of the intervention.

    4 month, 10 month

  • Function

    The short physical performance battery test is a function measure that utilizes 3 tasks scores 0-4 (total possible score of 12) to determine functional status and lower extremity function. Pre-test scores will be compared to post intervention test scores.

    4 month, 10 month

  • Lower Extremity Strength - Isometric Strength

    A measures of maximal isometric muscle strength produced in knee extensor muscles will be assessed with a Biodex device. Post-intervention levels will be compared to 6 months after the cessation of exercise.

    4 month, 10 month

  • Upper Extremity Strength - Grip Strength

    A measures of maximal isometric muscle strength produced in upper extremity muscles will be assessed by grip strength. Post-intervention levels will be compared to 6 months after the cessation of exercise.

    4 month, 10 month

Secondary Outcomes (3)

  • Rectus Femoris Muscle Thickness

    4 month, 10 month

  • Bicep Brachii Muscle Thickness

    4 month, 10 month

  • Middle Deltoid Muscle Thickness

    4 month, 10 month

Study Arms (2)

Exercise

EXPERIMENTAL

The participants will exercise 2 days a week for 16 weeks. The exercises will include 4 movements: squats, shoulder press, seated row, and bicep curl focusing on internal load and contraction velocity.

Other: Exercise

Usual Care

NO INTERVENTION

Participants will not have any study intervention visits for usual care.

Interventions

The participants will exercise 2 days a week for 16 weeks. The exercises will include 4 movements: squats, shoulder press, seated row, and bicep curl focusing on internal load and contraction velocity.

Exercise

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 55 years
  • Diagnosis of stage 3-4 CKD or an eGFR of \<45 mL/min/1.73m2

You may not qualify if:

  • Cardiovascular risk: Poorly controlled hypertension (\>160/100)
  • Coronary event in past 6 months
  • Class III or IV CHF
  • symptomatic angina at rest or during exercise
  • Syncope in past year, without known resolution of cause
  • COPD requiring home oxygen
  • Contraindications to resistance training, including history of intracranial or retinal bleeding; Diabetes with active proliferative retinopathy
  • History of significant spinal osteoarthritis or spinal stenosis
  • Dementia (on medical record review or mini-mental status exam score)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Rocky Mountain Regional VA Medical Center, Aurora, CO

Aurora, Colorado, 80045-7211, United States

NOT YET RECRUITING

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, 21201, United States

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Exercise

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Michael Harris-Love, DSc MPT BS

    Rocky Mountain Regional VA Medical Center, Aurora, CO

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Harris-Love, DSc MPT BS

CONTACT

Katie Boncella, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel study design features a Cohort Arm who will undergo regular assessments and observations for a minimum of 2 years. Participants who are hospitalized during the course of the study will undergo random assignment to an Exercise Group or a Usual Care group for 16-weeks.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2024

First Posted

September 23, 2024

Study Start

April 11, 2025

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

September 30, 2029

Last Updated

May 1, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations